Sit-stand desks reduce sitting but don’t lower blood pressure, and prolonged standing without movement may harm ...

Fact checked by Nick Blackmer A new study found a link between constipation and a higher risk of severe cardiovascular events ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

Discovery is seeking to introduce a new medical aid plan, aimed at addressing the healthcare needs of new entrants and young ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Discovery’s Active Smart plan, launching January 2025, offers young professionals affordable healthcare at R1,350 ...

Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Third Quarter 2024 Results Conference Call. At ...

Initially discovered and developed by Orion Corporation in Finland ... Results of Tenax Therapeutics’ Phase 2 HELP study of levosimendan in patients with pulmonary hypertension (PH) with heart failure ...

Pociredir is an investigational oral small-molecule inhibitor of Embryonic Ectoderm Development (EED) that was discovered using Fulcrum's proprietary ... heart disease, pulmonary hypertension, kidney ...

We also made the difficult but necessary decision to discontinue our in-house pro-drug discovery activities and close our ... While celiprolol is approved in Europe for hypertension, it is commonly ...

THE officer points a taser at her, but Virginia McCullough remains eerily calm – before quickly giving a full and frank ...